BCL2 and rheumatoid arthritis: In RA patients, the proinflammatory mediator AOPP accumulates and triggers a reduction in ROS produced in mitochondria by increasing BAX and cytochrome c in the cytosol, a phenomenon that triggers a decrease in the anti-apoptotic protein BCL-2 [212].